Compile Data Set for Download or QSAR
maximum 50k data
Found 56 Enz. Inhib. hit(s) with all data for entry = 743
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM38015(2-(2-fluoro-6-((4-(((1,1,1,3,3,3- hexafluoropropan...)
Affinity DataIC50:  550nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM38002(1-((5-fluoro-2-((4-(((1,1,1,3,3,3- hexafluoropropa...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM38005((1S,3R)-3-(2-((4-(((1,1,1,3,3,3- hexafluoropropan-...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM38006((1R,3R)-3-(2-((4-(((1,1,1,3,3,3- hexafluoropropan-...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM38007((1r,3r)-3-(2-((4-(((1,1,1,3,3,3- hexafluoropropan-...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM38009(4-(3-((4-(((1,1,1,3,3,3-hexafluoropropan-2- yl)oxy...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM38010(2-(2-chloro-6-((4-(((1,1,1,3,3,3- hexafluoropropan...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM38011(1,1,1,3,3,3-hexafluoropropan-2-yl 4-(3-chloro- 4-m...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM38012(1,1,1,3,3,3-hexafluoropropan-2-yl 4-(3-chloro- 2-(...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM38013(1,1,1,3,3,3-hexafluoropropan-2-yl 4-(4-chloro- 2-(...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM38014(1,1,1,3,3,3-hexafluoropropan-2-yl 4-(3-chloro- 4-m...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM38016(1,1,1,3,3,3-hexafluoropropan-2-yl 4-(2-((1- ((meth...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM38018(4-(2-chloro-6-((4- (((1,1,1,3,3,3- hexafluoropropa...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37967(2-(5-Chloro-2-((4-(((1,1,1,3,3,3- hexafluoropropan...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37970(2-(2-((4-(((1,1,1,3,3,3-Hexafluoropropan-2- yl)oxy...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37972(5-(2-((4-(((1,1,1,3,3,3-Hexafluoropropan-2- yl)oxy...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37973(1-(2-((4-(((1,1,1,3,3,3-Hexafluoropropan-2- yl)oxy...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37974(2-(3-((4-(((1,1,1,3,3,3-hexafluoropropan-2- yl)oxy...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37975(4-(2-((4-(((1,1,1,3,3,3-hexafluoropropan-2- yl)oxy...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37976(1-(3-((4-(((1,1,1,3,3,3-hexafluoropropan-2- yl)oxy...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37978(1,1,1,3,3,3-hexafluoropropan-2-yl 4-(3-fluoro- 4-m...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37979(1,1,1,3,3,3-hexafluoropropan-2-yl 4-(2-(2- (cyclop...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37980(1-(2-((4-(((1,1,1,3,3,3-Hexafluoropropan-2- yl)oxy...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37981(1-((2-Chloro-6-((4-(((1,1,1,3,3,3- hexafluoropropa...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37982(4-(2-Fluoro-6-((4-(((1,1,1,3,3,3- hexafluoropropan...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37983(4-(2-Fluoro-6-((4-(((1,1,1,3,3,3- hexafluoropropan...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37984(1-((2-Cyano-4-fluoro-6-((4-(((1,1,1,3,3,3- hexaflu...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37985(1-((2-((4-(((1,1,1,3,3,3-hexafluoropropan-2- yl)ox...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37951(1,1,1,3,3,3-Hexafluoropropan-2-yl 4-(2-((4- ethoxy...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37954(1,1,1,3,3,3-Hexafluoropropan-2-yl 4-(2-((4- (tert-...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37955(4-(2-((4-(((1,1,1,3,3,3-Hexafluoropropan-2- yl)oxy...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37956(4-(5-Chloro-2-((4-(((1,1,1,3,3,3- hexafluoropropan...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37957(1,1,1,3,3,3-Hexafluoropropan-2-yl 4-(2-((4-(1- ((e...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37960(1,1,1,3,3,3-Hexafluoropropan-2-yl 4-(2-((4-(1- ((i...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37961(1,1,1,3,3,3-Hexafluoropropan-2-yl 4-(2-((4- oxo-4-...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37962(1,1,1,3,3,3-Hexafluoropropan-2-yl 4-(2-((4-(1- (is...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37963(2-(2-((2-((4-(((1,1,1,3,3,3-Hexafluoropropan-2- yl...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37964(2-(2-((4-Chloro-2-((4-(((1,1,1,3,3,3- hexafluoropr...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37986(1-((3-((4-(((1,1,1,3,3,3-hexafluoropropan-2- yl)ox...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37987(1-((2-fluoro-6-((4-(((1,1,1,3,3,3- hexafluoropropa...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37988(1-((2-((4-(((1,1,1,3,3,3-hexafluoropropan-2- yl)ox...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37990(1,1,1,3,3,3-hexafluoropropan-2-yl 4-(3-fluoro- 4-m...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37991(1-((2-fluoro-6-((4-(((1,1,1,3,3,3- hexafluoropropa...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37992(1-((2,3-difluoro-6-((4-(((1,1,1,3,3,3- hexafluorop...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37993(1-((4,5-difluoro-2-((4-(((1,1,1,3,3,3- hexafluorop...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37994(1-((5-cyano-2-((4-(((1,1,1,3,3,3- hexafluoropropan...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37995(1-((2-cyano-6-((4-(((1,1,1,3,3,3- hexafluoropropan...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37996(1-((2,3-difluoro-6-((4-(((1,1,1,3,3,3- hexafluorop...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37997(1-((3-fluoro-6-((4-(((1,1,1,3,3,3- hexafluoropropa...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM37998(1-((4-fluoro-2-((4-(((1,1,1,3,3,3- hexafluoropropa...)
Affinity DataIC50:  5.50E+3nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 56 total ) | Next | Last >>
Jump to: